Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kiniksa Pharmaceuticals L...

    NASDAQ: KNSA · Real-Time Price · USD
    33.30
    0.02 (0.06%)
    At close: Aug 15, 2025, 3:05 PM

    Kiniksa Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -43.19M 14.08M 183.36M -157.92M
    Depreciation & Amortization
    		 1.7M 2.34M 2.4M 2.35M
    Stock-Based Compensation
    		 30.69M 27.15M 25.12M 25.17M
    Other Working Capital
    		 46.81M 11.48M -2.01M 6.91M
    Other Non-Cash Items
    		 3.55M 2.17M 2.99M 3.4M
    Deferred Income Tax
    		 8.13M -33.79M -185.5M 11K
    Change in Working Capital
    		 24.81M 1.35M -22.57M 689K
    Operating Cash Flow
    		 25.69M 13.3M 5.81M -126.3M
    Capital Expenditures
    		 -277K -130K -105K -20.41M
    Cash Acquisitions
    		 n/a n/a 91K 20M
    Purchase of Investments
    		 -202.01M -204.93M -135.86M -157.25M
    Sales Maturities Of Investments
    		 239.94M 175.51M 127.8M 306.3M
    Other Investing Acitivies
    		 25K n/a -7.97M -20M
    Investing Cash Flow
    		 37.67M -29.56M -8.08M 128.63M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 -4.98M -2.21M -901K 5.88M
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 17.25M 3.7M -901K 5.88M
    Financial Cash Flow
    		 12.27M 1.5M 2.52M 5.88M
    Net Cash Flow
    		 75.63M -14.76M 245K 8.22M
    Free Cash Flow
    		 25.41M 13.17M 5.7M -146.71M

    Add to Watchlist